Brian Czerniecki, MD, PhD, leads Penn study that shows protein predicts development of invasive breast cancer in women with DCIS


May 22, 2009

Penn Medicine News

Women with ductal carcinoma in situ (DCIS) who exhibit an overexpression of the protein HER2/neu have a six-fold increase in risk of invasive breast cancer, according to a new study led by Brian Czerniecki, MD, PhD, Co-Director of the Rena Rowan Breast Center and Surgical Director of the Immunotherapy Program for the Abramson Cancer Center. The results, published in the May issue of the journal Cancer Epidemiology, Biomarkers and Prevention, may help clinicians distinguish between DCIS that requires minimal treatment and DCIS that should be treated more aggressively... Read More